cyanopindolol has been researched along with ergotamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bax, WA; Bos, E; Renzenbrink, GJ; Saxena, PR; Thijssen, EJ; Van Heuven-Nolsen, D | 1 |
| Bai, F; Cherezov, V; Gao, X; Han, GW; Huang, XP; Jiang, H; Jiang, Y; Katritch, V; Liu, W; Ma, J; McCorvy, JD; Melcher, K; Roth, BL; Stevens, RC; Vardy, E; Wacker, D; Wang, C; Wu, H; Xu, HE; Yang, H; Yang, L; Zhang, C; Zhou, XE | 1 |
2 other study(ies) available for cyanopindolol and ergotamine
| Article | Year |
|---|---|
5-HT receptors mediating contractions of the isolated human coronary artery.
Topics: Adolescent; Adult; Arteries; Blood Platelets; Child; Child, Preschool; Coronary Vessels; Dose-Response Relationship, Drug; Ergotamine; Female; Humans; In Vitro Techniques; Infant; Ketanserin; Male; Metergoline; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Pindolol; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Sumatriptan; Yohimbine | 1993 |
Structural basis for molecular recognition at serotonin receptors.
Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Dihydroergotamine; Ergotamine; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Lysergic Acid Diethylamide; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Mutagenesis; Norfenfluramine; Pindolol; Propranolol; Protein Conformation; Protein Folding; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2013 |